Safety and governance

Assurance status.

Every standard a buyer or reviewer is likely to ask about, with a factual status. We do not use badges, and we only give dates that are confirmed.

Register reviewed 14 November 2026.

Assurance register

0 Completed and evidenced2 In progress6 Planned2 Not yet assessed1 Not applicable
  • Clinical safety

    DCB0129 — clinical risk management in the manufacture of health IT

    In progress
    Today
    An engineering draft of the hazard log and a safety-case outline exist alongside the build. Severities are provisional. No Clinical Safety Officer has been appointed, so none has reviewed them, and they are not a safety case.
    Next · what would change this status
    Appoint a suitably qualified Clinical Safety Officer; establish the clinical risk management file, plan and hazard log under their approval before any use with real patient data.
    Why it matters and the reference
    Why it matters
    Manufacturers of health IT use DCB0129 to identify and control clinical hazards. Deploying organisations need the supplier’s clinical safety case report for their own DCB0160 work.
  • Clinical safety

    DCB0160 — clinical risk management in the deployment and use of health IT

    Not applicable
    Today
    DCB0160 is completed by the organisation deploying a system, such as a GP practice. It is not Reedley’s standard to complete, but Reedley will provide the information a practice needs for its own assessment.
    Next · what would change this status
    Prepare a deployment pack for pilot sites: the supplier safety case report, hazard log extract and the intended-use statement.
    Why it matters and the reference
    Why it matters
    A practice remains responsible for safe deployment and needs supplier evidence to do it.
  • Regulation

    Medical device qualification (MHRA, UK MDR 2002)

    Not yet assessed
    Today
    Reedley has not determined whether any part of the product is a medical device. The founder has recorded a working hypothesis per feature; features that shape prescribing decisions may fall within scope. No specialist has reviewed that hypothesis.
    Next · what would change this status
    Commission a regulatory specialist assessment against MHRA guidance before any clinical use, and register with the MHRA if required.
    Why it matters and the reference
    Why it matters
    Intended purpose, including how the product is described in marketing, decides device status. This website is written with that in mind.
  • Procurement

    DTAC — Digital Technology Assessment Criteria (version 2.0)

    Planned
    Today
    Not started. DTAC covers clinical safety, data protection, technical security, interoperability, and usability and accessibility, so it depends on the items above.
    Next · what would change this status
    Complete the DTAC v2.0 form once clinical safety, data protection and security evidence exist.
    Why it matters and the reference
    Why it matters
    Care providers and commissioners use DTAC to check that digital health technologies meet national baseline standards.
  • Information governance

    DSPT — Data Security and Protection Toolkit

    Planned
    Today
    Not started. Reedley does not currently process any NHS patient data.
    Next · what would change this status
    Register and complete the toolkit before Reedley has access to any NHS patient data or systems.
    Why it matters and the reference
    Why it matters
    All organisations with access to NHS patient data and systems must use the toolkit.
    Reference
    DSPT
  • Data protection

    ICO registration and supplier DPIA (UK GDPR)

    Planned
    Today
    No patient data is processed today. The website collects business contact details only, as described in the privacy notice. Registration with the Information Commissioner’s Office (the data protection fee) is not yet in place, and no form is switched on until it is: by the founder as data controller until the company is incorporated, then by the company.
    Next · what would change this status
    Pay the ICO data protection fee before any website form is switched on, and again for the company once it exists; prepare a supplier DPIA template for pilot practices before any patient data is processed.
    Why it matters and the reference
    Why it matters
    A practice will need to complete its own DPIA for any tool that processes patient data, and will expect supplier input.
  • Security

    Cyber Essentials and Cyber Essentials Plus

    Planned
    Today
    Not yet certified.
    Next · what would change this status
    Certify Cyber Essentials, then Cyber Essentials Plus, before handling any patient data.
    Why it matters and the reference
    Why it matters
    A recognised baseline for organisations that handle personal data; expected by many NHS buyers.
  • Security

    Independent penetration test

    Planned
    Today
    Not commissioned. During development the website has had automated security checks run by the build and code reviews by AI review agents. No person has carried out a security test and none of it is independent, so it does not replace an independent test.
    Next · what would change this status
    Commission an independent test of the product before any pilot with real data, and of the website after launch.
    Why it matters and the reference
    Why it matters
    Independent testing finds what internal review misses.
  • Integration

    Clinical-system integration (for example IM1 pairing)

    Not yet assessed
    Today
    No integration with EMIS Web, EMIS-X or SystmOne exists or is claimed. The build runs against a simulated clinical system. Integration routes have been researched; no application has been made.
    Next · what would change this status
    Make formal enquiries through the published supplier and national routes. Publish each step here as it happens.
    Why it matters and the reference
    Why it matters
    IM1 pairing has its own assurance stages. NHS England states that it does not include AI-specific technical assurance, which Reedley must carry itself.
  • Accessibility

    WCAG 2.2 level AA (this website)

    In progress
    Today
    This website has WCAG 2.2 AA as its target and was checked during development with automated tests run by the build, including scripted keyboard checks, and by AI review agents. No person has audited it, and it has not had an independent audit.
    Next · what would change this status
    Independent accessibility review of the website and, separately, of the product before any pilot.
    Why it matters and the reference
    Why it matters
    Clinicians and staff with access needs must be able to use the tools they are given.
  • Clinical evaluation

    Real-world evaluation with practices

    Planned
    Today
    No clinician has used Reedley yet. A walkthrough pack for synthetic-data sessions and a pilot protocol are drafted. One model-in-the-loop run on synthetic development documents exists; the locked holdout has not been sent to a model.
    Next · what would change this status
    Founder walkthrough, then independent GP and pharmacist walkthroughs on synthetic data, reported separately; then a governed pilot.
    Why it matters and the reference
    Why it matters
    Usefulness and safety must be shown, not asserted.

Status vocabulary: completed and evidenced; in progress; planned; not yet assessed; not applicable (with the reason). Nothing on this page indicates approval, certification or endorsement by the NHS, NHS England, the MHRA or any other body.

Next steps

Need something specific?

If your organisation needs evidence that is not listed here, ask us. If it does not exist yet, we will say so.

  1. See it work

    A scripted walkthrough of a synthetic clinic letter, from receipt to evidence. Pause or step through it at any point.

    Take the 90-second tour
  2. Share it

    Ten short sections for partners, PCN leads and digital staff, written to be forwarded without a conversation first.

    Read the evaluation pack
  3. Talk to us

    Registering interest takes about a minute. A conversation is with Salim Miah, founder (MPharm, independent prescriber).

Questions buyers ask

What will it cost?

Pricing has not been set. Pilot participation would be agreed individually; we will not ask a practice to pay for something that is not ready.

Who is building Reedley?

Reedley is at an early stage and is currently founder-led. Its founder, Salim Miah MPharm, is a UK-qualified pharmacist and independent prescriber who has worked across community pharmacy, hospital and general practice.

As Reedley grows, clinical safety, engineering and information governance roles will be filled by suitably qualified people, and we will name them here.

How much of our team’s time does a pilot take?

Stage 1 is about an hour; registering interest takes about a minute and applying about five minutes.

Stages 2–4 are agreed with you in the conversation; we will not guess.

Does it work with EMIS Web or SystmOne?

Not today. Reedley is designed around EMIS Web workflows, but no integration exists, none is claimed, and no supplier has approved or partnered with Reedley.

We intend to pursue the published integration routes, such as IM1 pairing, and will report each step on the integration page.

The same applies as for EMIS Web: designed for SystmOne workflows, with no integration existing or claimed.

All questions and answers